The recent surge in new treatments for kidney diseases has made it more challenging for nephrologists to maintain ...

Only 13 kidney transplants have been performed in five years. Similarly, the hospital averages 50 angioplasty surgeries per ...

The NEDC, in collaboration with the Nigeria Association of Nephrology, has marked World Kidney Day in Yola with a strong call ...

Administration of aminophylline at the initiation of therapeutic hypothermia (TH) in neonates with hypoxic-ischemic encephalopathy (HIE) was associated with a greater decline in serum ...

Monday’s FDA approval makes Filspari the first therapy specifically indicated for FSGS, a condition that represents a $1 ...

Compared with placebo, semaglutide lowered risks for adverse kidney outcomes and mortality across the chronic kidney disease spectrum, according to study data published in Clinical Journal of the ...

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved ...

Recently analyzed evidence points to a connection between oral health and kidney health, according to work led by University ...

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Since imposing a $100,000 fee on new visas in September, the Trump administration has upended the skilled worker program.

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

A new UC Davis Health study reveals that transportation challenges create major barriers for patients with end-stage kidney ...